Phenotypic analysis of images of zebrafish treated with Alzheimer's γ-secretase inhibitors
<p>Abstract</p> <p>Background</p> <p>Several γ-secretase inhibitors (GSI) are in clinical trials for the treatment of Alzheimer's disease (AD). This enzyme mediates the proteolytic cleavage of amyloid precursor protein (APP) to generate amyloid β protein, Aβ, the p...
Main Authors: | Augelli-Szafran Corinne E, Wong Stephen T, Xu Xiaoyin, Yang Ting, Arslanova Dilyara, Xia Weiming |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Biotechnology |
Online Access: | http://www.biomedcentral.com/1472-6750/10/24 |
Similar Items
-
Turning the tide on Alzheimer’s disease: modulation of γ-secretase
by: Joanna E. Luo, et al.
Published: (2022-01-01) -
FAD Mutations in Presenilin-1 or Amyloid Precursor Protein Decrease the Efficacy of a γ-Secretase Inhibitor: Evidence for Direct Involvement of PS1 in the γ-Secretase Cleavage Complex
by: Weiming Xia, et al.
Published: (2000-12-01) -
γ-secretase inhibitors and modulators induce distinct conformational changes in the active sites of γ-secretase and signal peptide peptidase
by: Gertsik, Natalya, et al.
Published: (2015) -
Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease
by: Michael S. Wolfe
Published: (2021-01-01) -
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01)